Paper31840366
Endothelium-dependent and independent coronary microvascular dysfunction in patients with heart failure with preserved ejection fraction.
Yang JH and 5 others. Eur J Heart Fail, 2020. Cited by 151 papers, by iCite.
Cite this record
ConductScience Library. Endothelium-dependent and independent coronary microvascular dysfunction in patients with heart failure with preserved ejection fraction. Papers, record 31840366. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/31840366
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Endothelium-dependent and independent coronary microvascular dysfunction in patients with heart failure with preserved ejection fraction.
- PubMed
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Heart Failure | Major topic |
| Diastole | |
| Endothelium | |
| Female | |
| Heart Ventricles | |
| Humans | |
| Male | |
| Stroke Volume | |
| Ventricular Function, Left |
Source PubMed
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| R01 HL128526 | NHLBI NIH HHS | United States | R01HL128526 | PubMed and NIH | NIH RePORTER |
| U10 HL110262 | NHLBI NIH HHS | United States | U10HL110262 | PubMed and NIH | NIH RePORTER |
Trials1
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record |
|---|---|---|---|
| NCT06217120 | Reversing Microvascular Dysfunction in Heart Failure With Preserved Ejection Fraction | Background |
Source ClinicalTrials.gov
Comments and corrections1
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers |
|---|---|---|---|
| Comment in | 31912570 | Coronary microvascular dysfunction in heart failure with preserved ejection fraction - adding new pieces to the jigsaw puzzle. | https://conductscience.org/library/papers/31912570 |
Source PubMed
Cited by102
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 151 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42866227 | Bidirectional metabolic-vascular feedback loops in heart failure: From myocardial energetics to multisystem cardiometabolic crosstalk. | iScience | 2026 | https://conductscience.org/library/papers/42866227 | PubMed |
| 42818248 | Physiological Aging and Cardiovascular Disease Distinctly Remodel the Human Cardiac Lymphatic Endothelium. | bioRxiv | 2026 | https://conductscience.org/library/papers/42818248 | PubMed |
| 42762037 | Heart Failure with Reduced versus Preserved Ejection Fraction: Molecular Mechanisms, Immunologic Pathways, Current Therapies, and Future Directions. | Arch Intern Med Res | 2026 | https://conductscience.org/library/papers/42762037 | PubMed |
| 42741582 | Relationship of Cardiopulmonary Exercise Capacity to Coronary Microvascular Function and Body Composition in Patients with Suspected Heart Failure with Preserved Ejection Fraction. | Card Fail Rev | 2026 | https://conductscience.org/library/papers/42741582 | PubMed |
| 42675506 | Women's heart and echocardiography. | J Cardiovasc Imaging | 2026 | https://conductscience.org/library/papers/42675506 | PubMed |
| 42645729 | Beyond biomarkers: designer natriuretic peptides and cGMP centered therapies for cardiorenal and cardiometabolic protection in chronic heart failure. | Intern Emerg Med | 2026 | https://conductscience.org/library/papers/42645729 | PubMed |
| 42548607 | Functional coronary vascular disease: endotype-based classification, diagnosis, and targeted management. | Front Cardiovasc Med | 2026 | https://conductscience.org/library/papers/42548607 | PubMed |
| 42509570 | Sex differences in microvascular patterns associated with low- and high-risk for cardiovascular disease. | Biol Sex Differ | 2026 | https://conductscience.org/library/papers/42509570 | PubMed |
| 42389437 | Inflammation, metabolism, and aging in heart failure with preserved ejection fraction: Mechanisms and treatment perspectives. | J Transl Int Med | 2026 | https://conductscience.org/library/papers/42389437 | PubMed |
| 42374613 | Spontaneous Helical Alignment of Smooth Muscle Cells to Form a Medial Layer for Engineered Microvasculature. | Adv Healthc Mater | 2026 | https://conductscience.org/library/papers/42374613 | PubMed |
| 42217147 | Ocular microvascular alterations in patients with heart failure with preserved ejection fraction. | Jpn J Ophthalmol | 2026 | https://conductscience.org/library/papers/42217147 | PubMed |
| 42089212 | Incremental Prognostic Power of Coronary Flow Reserve and Artificial Intelligence-Enabled ECG-Derived Filling Pressure in Angina With Nonobstructive Coronary Arteries. | J Am Heart Assoc | 2026 | https://conductscience.org/library/papers/42089212 | PubMed |
| 41627604 | Heart Failure with Preserved Ejection Fraction and Diastolic Dysfunction in Patients with Chronic Obstructive Pulmonary Disease: a Systematic Review. | Curr Heart Fail Rep | 2026 | https://conductscience.org/library/papers/41627604 | PubMed |
| 41528276 | Implications of Potential Undiagnosed HFpEF on Symptomatic Response With Coronary Revascularization. | JACC Heart Fail | 2026 | https://conductscience.org/library/papers/41528276 | PubMed |
| 41425993 | Heart failure: mechanistic insights and precision therapeutic strategies. | Front Cardiovasc Med | 2025 | https://conductscience.org/library/papers/41425993 | PubMed |
| 41220152 | Prevention and Reversal of Hypertension-Induced Coronary Microvascular Dysfunction by a Plant-Based Diet. | J Am Heart Assoc | 2025 | https://conductscience.org/library/papers/41220152 | PubMed |
| 40960442 | Is Type 2 Diabetes a Modifiable Risk Factor for the Evolution and Progression of Heart Failure With a Preserved Ejection Fraction? | J Am Coll Cardiol | 2025 | https://conductscience.org/library/papers/40960442 | PubMed |
| 40943688 | Decreased Endogenous Nitric Oxide Production in Patients with Acute Decompensated Heart Failure with Preserved Ejection Fraction. | J Clin Med | 2025 | https://conductscience.org/library/papers/40943688 | PubMed |
| 40834289 | Coronary microvascular disease in heart failure with preserved ejection fraction. | Physiol Rep | 2025 | https://conductscience.org/library/papers/40834289 | PubMed |
| 40823618 | Underpinnings of heart failure with preserved ejection fraction in women - From prevention to improving function. A co-publication with the American Journal of Preventive Cardiology and the Journal of Cardiac Failure. | Am J Prev Cardiol | 2025 | https://conductscience.org/library/papers/40823618 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/31840366
GET https://conductscience.org/api/papers/v1/31840366/cited_by?page=2